본문 바로가기
bar_progress

Text Size

Close

[eDisclosure Notice] KOSPI - 17th

[Asia Economy Reporter Lee Seon-ae]



▲Celltrion=Obtained domestic product modification approval from the Ministry of Food and Drug Safety for the COVID-19 treatment drug ‘Rekkironaju (CT-P59)’


▲SKC=Decision not to designate as an unfaithful disclosure corporation


▲KT=Invested 175 billion KRW in affiliate KT Studio Genie


▲Hanjin Heavy Industries=Conclusion of joint management procedure with bond financial institutions


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top